Principal Financial Group Inc Amgen Inc Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $11.1 Million - $12.1 Million	35,785 Added 5.97%	635,172 $205 Million
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $3.73 Million - $4.54 Million	-14,203 Reduced 2.31%	599,387 $187 Million
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $1.26 Million - $1.52 Million	-4,689 Reduced 0.76%	613,590 $174 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $1.64 Million - $1.85 Million	-6,426 Reduced 1.03%	618,279 $178 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $2.09 Million - $2.6 Million	-9,570 Reduced 1.51%	624,705 $168 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $3.03 Million - $3.59 Million	-14,160 Reduced 2.18%	634,275 $141 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $1.3 Million - $1.58 Million	5,740 Added 0.89%	648,435 $157 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $3.23 Million - $4.11 Million	-14,120 Reduced 2.15%	642,695 $169 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $3.2 Million - $3.61 Million	-14,257 Reduced 2.12%	656,815 $148 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $747,961 - $832,351	-3,242 Reduced 0.48%	671,072 $163 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $2.85 Million - $3.16 Million	-13,015 Reduced 1.89%	674,314 $163 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $4.16 Million - $4.76 Million	-20,900 Reduced 2.95%	687,329 $155 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $1.51 Million - $1.77 Million	-7,119 Reduced 1.0%	708,229 $151 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $517,379 - $573,995	2,215 Added 0.31%	715,348 $174 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $16.7 Million - $19.5 Million	-75,308 Reduced 9.55%	713,133 $177 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $40.5 Million - $48.2 Million	-187,064 Reduced 19.18%	788,441 $181 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $17.9 Million - $19.9 Million	-76,273 Reduced 7.25%	975,505 $248 Million
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $23.4 Million - $28.7 Million	118,269 Added 12.67%	1,051,778 $248 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $2.86 Million - $3.79 Million	-15,667 Reduced 1.65%	933,509 $189 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $19.4 Million - $24.9 Million	-102,297 Reduced 9.73%	949,176 $229 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $7.53 Million - $9.03 Million	-43,276 Reduced 3.95%	1,051,473 $203 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $555,777 - $651,496	-3,334 Reduced 0.3%	1,094,749 $202 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $5.51 Million - $6.21 Million	-30,456 Reduced 2.7%	1,098,083 $209 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $18.6 Million - $21.7 Million	-103,985 Reduced 8.44%	1,128,539 $220 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $8.5 Million - $9.59 Million	-45,899 Reduced 3.59%	1,232,524 $255 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $15.1 Million - $16.9 Million	90,664 Added 7.63%	1,278,423 $0
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $2.7 Million - $3.16 Million	15,948 Added 1.36%	1,187,759 $202 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $145,834 - $162,941	-864 Reduced 0.07%	1,171,811 $204 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $196 Million - $224 Million	1,172,675	1,172,675 $219 Million

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account